The emergence of inhalable RNA therapeutics and challenges faced - where to from here?
作者信息
Haque Shadabul, Kaminskas Lisa M
机构信息
Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.
出版信息
Nanomedicine (Lond). 2025 Feb;20(3):251-253. doi: 10.1080/17435889.2024.2429368. Epub 2024 Nov 24.
Abstract
摘要
相似文献
1
The emergence of inhalable RNA therapeutics and challenges faced - where to from here?可吸入RNA疗法的出现及面临的挑战——何去何从？
Nanomedicine (Lond). 2025 Feb;20(3):251-253. doi: 10.1080/17435889.2024.2429368. Epub 2024 Nov 24.
2
Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research.可吸入纳米颗粒干粉制剂治疗呼吸系统疾病：转化研究的挑战与策略。
AAPS PharmSciTech. 2023 Apr 4;24(4):98. doi: 10.1208/s12249-023-02559-y.
3
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives.肺部给药的纳米制剂：过去、现在与未来展望
Pharmaceutics. 2024 Jan 24;16(2):161. doi: 10.3390/pharmaceutics16020161.
4
Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route.用于将 mRNA 递送至呼吸道的脂质纳米颗粒：PEG-脂质含量和给药途径的影响。
Eur J Pharm Biopharm. 2024 May;198:114266. doi: 10.1016/j.ejpb.2024.114266. Epub 2024 Mar 16.
5
Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration.吸入型 mRNA 纳米颗粒，具有增强的雾化稳定性和肺部微环境渗透能力。
ACS Nano. 2024 Sep 3;18(35):24204-24218. doi: 10.1021/acsnano.4c05653. Epub 2024 Aug 22.
6
Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents.基于亚微米颗粒的气溶胶策略在治疗剂高效全身递送方面的进展。
Curr Pharm Des. 2016;22(17):2470-80. doi: 10.2174/1381612822666160225155637.
7
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model.可吸入纳米颗粒，一种非侵入性方法，用于治疗小鼠模型中的肺癌。
J Control Release. 2011 Feb 28;150(1):49-55. doi: 10.1016/j.jconrel.2010.10.035. Epub 2010 Nov 6.
8
Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.小干扰RNA（siRNA）肺部气溶胶递送。第2部分：基于纳米载体的递送系统。
Kona. 2017;34:44-69. doi: 10.14356/kona.2017005. Epub 2016 Apr 30.
9
Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases.用于治疗和预防肺部感染性疾病的可吸入纳米药物的制剂与临床转化
Drug Deliv Transl Res. 2025 Apr 29. doi: 10.1007/s13346-025-01861-5.
10
Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung.用于肺部吸入信使 RNA 递送至肺部的通用聚合物制剂。
Nat Mater. 2023 Mar;22(3):369-379. doi: 10.1038/s41563-022-01404-0. Epub 2022 Nov 28.
本文引用的文献
1
Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency.核酸肺部递呈技术克服生理屏障并提高转染效率的最新进展。
Adv Sci (Weinh). 2024 May;11(18):e2309748. doi: 10.1002/advs.202309748. Epub 2024 Mar 9.
2
Recent advances in nanoparticulate RNA delivery systems.纳米颗粒 RNA 递释系统的最新进展。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307798120. doi: 10.1073/pnas.2307798120. Epub 2024 Mar 4.
3
Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol.雾化 RNA 制剂递送至肺部：从气溶胶到细胞质。
J Control Release. 2024 Feb;366:812-833. doi: 10.1016/j.jconrel.2023.12.012. Epub 2024 Jan 25.
4
Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano-bio interactions.吸入式 RNA 药物治疗肺部疾病：与疾病相关的细胞和纳-生物相互作用。
Adv Drug Deliv Rev. 2023 Dec;203:115144. doi: 10.1016/j.addr.2023.115144. Epub 2023 Nov 22.
5
Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats.大鼠体内临床相关脂质纳米颗粒引发的聚乙二醇（PEG）相关免疫反应。
NPJ Vaccines. 2023 Nov 2;8(1):169. doi: 10.1038/s41541-023-00766-z.
6
Development of lung tissue models and their applications.肺组织模型的开发及其应用。
Life Sci. 2023 Dec 1;334:122208. doi: 10.1016/j.lfs.2023.122208. Epub 2023 Oct 24.
7
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.用于体内 RNA 递送的脂质纳米颗粒 (LNPs) 及其未来应用的突破性技术。
Adv Drug Deliv Rev. 2023 Sep;200:114990. doi: 10.1016/j.addr.2023.114990. Epub 2023 Jul 7.
8
Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates.iSEND 纳米粒递呈的地塞米松经吸入途径给药可减轻 COVID-19 小鼠和非人灵长类动物的细胞因子风暴。
Sci Adv. 2023 Jun 16;9(24):eadg3277. doi: 10.1126/sciadv.adg3277. Epub 2023 Jun 14.
9
Liposomes are Poorly Absorbed Lung Lymph After Inhaled Administration in Sheep.脂质体经吸入给药后在绵羊肺部淋巴中的吸收较差。
Front Pharmacol. 2022 Jun 2;13:880448. doi: 10.3389/fphar.2022.880448. eCollection 2022.
10
RNA therapy: rich history, various applications and unlimited future prospects.RNA 疗法：丰富的历史、多样的应用和无限的未来前景。
Exp Mol Med. 2022 Apr;54(4):455-465. doi: 10.1038/s12276-022-00757-5. Epub 2022 Apr 19.
Zotero 插件